SNHG6 and neoplasm: The study also reveals that this inhibition occurs through the targeting of ETS1 via the PI3K/AKT/mTOR pathway and this implies that SNHG6 might act as a tumor suppressor in the context of colorectal cancer, as opposed to its oncogenic role in other cancer types.